KGF and EGF differentially regulate the phenotype of prostatic epithelial cells

Growth Regulation

Volumn 6, Issue 1, 1996, Pages 22-31

  Peehl, D M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Differentiation; Epidermal growth factor; Fibroblast growth factor; Keratin; Keratinocyte growth factor; Prostate; Retinoic acid

Indexed keywords

EPIDERMAL GROWTH FACTOR; KERATIN; KERATINOCYTE GROWTH FACTOR; PROSTATE SPECIFIC ANTIGEN; RETINOIC ACID; SURAMIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIUM CELL; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; MALE; PHENOTYPE; PROSTATE EPITHELIUM;

CELL DIVISION; CELLS, CULTURED; CLONE CELLS; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; EPITHELIUM; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; GROWTH SUBSTANCES; HUMANS; KERATINS; MALE; PHENOTYPE; PROSTATE; PROSTATIC NEOPLASMS; RECOMBINANT PROTEINS; TRETINOIN;

EID: 0029875032     PISSN: 0956523X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Finch P W, Rubin J S, Miki T, Ron D, Aaronson S A. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 1989; 245: 752-755.
2. Rubin J S, Osada H, Finch P W, Taylor W G, Rudikoff S, Aaronson S A. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sei USA 1989; 86: 802-806.
3. Cunha G R, Chung L W K, Shannon J M, Taguchi O, Fujii H. Hormone-induced morphogenesis and growth: role of mesenchymal-epithelial interactions. Recent Prog Horm Res 1983; 39: 559-598.
4. Yan G, Fukabori Y, Nikolaropoulos S, Wang F, McKeehan W L. Heparin-binding keratinocyte growth factor is a candidate stromal to epithelial cell andromedin. Mol Endocrin 1992; 6: 2123-2128.
5. McKeehan W L, Adams P S, Rosser M P. Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture. Cancer Res 1984; 44: 1998-2010.
6. Peehl D M, Wong S T, Bazinet M, Stamey T A. In vitro studies of human prostatic epithelial cells: attempts to identify distinguishing features of malignant cells. Growth Factors 1989; 1: 237-250.
7. MacDonald A, Habib F K. Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. Br J Cancer 1992; 65: 177-182.
8. Wilding G, Valverius E, Knabbe C, Gelman E P. Role of transforming growth factor-a in human prostate cancer cell growth. Prostate 1989; 15: 1-12.
9. Fowler J E Jr, Lau J L T, Ghosh L, Mills S E, Mounzer A. Epidermal growth factor and prostatic carcinoma: an immunohistochemical study. J Urol 1988; 139: 857-861.
10. Jacobs S C, Story M T. Exocrine secretion of epidermal growth factor by the rat prostate: effect of adrenergic agents, cholinergic agents, and vasoactive intestinal peptide. Prostate 1988; 13: 79-87.
11. Nishi N, Matuo Y, Wada F. Partial purification of a major type of rat prostatic growth factor: characterization as an epidermal growth factor-related mitogen. Prostate 1988; 13: 209-220.
12. Ching K Z, Ramsey E, Pettigrew N, D'Cunha R, Jason M, Dodd J G. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol Cell Biochem 1993; 126: 151-158.
13. Harper M E, Goddard L, Glynne-Jones E, Wilson D W, Price-Thomas M, Peeling W B, Griffiths K. An immunocytochemical analysis of TGFa expression in benign and malignant prostatic tumors. Prostate 1993; 23: 9-23.
14. Yang Y, Chisholm G D, Habib F K. Epidermal growth factor and transforming growth factor a concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels. Br J Cancer 1993; 67: 152-155.
15. Morris G L, Dodd J G. Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J Urol 1990; 143: 1272-1274.
16. Fox S B, Persad R A, Coleman N, Day C A, Silcocks P B, Collins C C. Prognostic value of c-erbB-2 and epidermal growth factor receptor in stage Al (Tla) prostatic adenocarcinoma. Br J Urol 1994; 74: 214-220.
17. Peehl D M. Culture of human prostatic epithelial cells. In: Culture of Epithelial Cells, Freshney RI, (ed). New York, NY: Wiley-Liss, Inc, 1992: 159-180.
18. McNeal J E, Kindrachuk R A, Freiha F S, Bostwick D G, Redwine E A, Stamey T A. Patterns of progression in prostatic cancer. Lancet 1986; 1: 60-63.
19. Peehl D M. Serial culture of adult human prostatic epithelial cells. J Tissue Culture Methods 1985; 9: 53-60.
20. Ron D, Bottaro D P, Finch P W, Morris D, Rubin J S, Aaronson S A. Expression of biologically active recombinant keratinocyte growth factor. J Biol Chem 1993; 268: 2984-2988.
21. Peehl D M, Wong S T, Stamey T A. Clonal growth characteristics of adult human prostatic epithelial cells. In Vitro 1988; 24: 530-536.
22. Brawer M K, Peehl D M, Stamey T A, Bostwick D G. Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res 1985; 45: 3663-3667.
23. Feitz W F J, Debruyne F M J, Vooijs G P, Herman C J, Ramaekers FCS. Intermediate filament proteins as tissue specific markers in normal and malignant urological tissues J Urol 1986; 136: 922-931.
24. Peehl D M, Leung G K, Wong S T. Keratin expression: a measure of phenotypic modulation of human prostatic epithelial cells by growth inhibitory factors. Cell Tissue Res 1994; 277: 11-18.
25. Verhagen A P M, Ramaekers PCS, Aalders T W, Schaafsma H E, Dcbruyne F M J, Schalken J A. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res 1992; 52: 6182-6187.
26. Peehl D M, Wong S T, Stamey T A. Cytostatic effects of suramin on prostatic cancer cells cultured from primary tumors. J Urol 1991; 145: 624-630.
27. Peehl D M, Wong S T, Stamey T A. Vitamin A regulates proliferation and differentiation of human prostatic epithelial cells. Prostate 1993; 23: 69-78.
28. Nagle R B, Drawer M K, Kittleson J, Clark V. Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma. Am J Path 1991; 138: 119-128.
29. Shipley G D, Keeble W W, Hendrickson J E, Coffey R J Jr, Pittelkow M R. Growth of normal human keratinocytes and fibroblasts in serum-free medium is stimulated by acidic and basic fibroblast growth factor. J Cell Physiol 1989; 138: 511-518.
30. Sherwood E R, Fong C-J, Lee C, Kozlowski J M. Basic fibroblast growth factor: a potential'mediator of stromal growth in the human prostate. Endocrinology 1992; 130: 2955-2963.
31. Gospodarowicz D, Newfeld G, Schweigerer L. Fibroblast growth factor: structural and biological properties. J Cell Physiol Suppl 1987; 5: 15-26.
32. Johnson D E, Williams L T. Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 1993; 60: 1-41.
33. Carpenter G, Cohen S. Epidermal growth factor. J Biol Chem 1990; 265: 7709-7712.
34. Peehl D M, Stamey T A. Serum-free growth of adult human prostatic epithelial cells. In-Vitro 1986; 22: 82-90.
35. Folkman J, Moscona A. Role of cell shape in growth control. Nature 1978; 273: 345-349.
36. Gospodarowicz D, Greenburg G, Birdwell C R. Determination of cellular shape by the extracellular matrix and its correlation with the control of cellular growth. Cancer Res 1978; 38: 4155-4171.
37. Stein C A, LaRocca R V, Thomas R, McAtee N, Myers C E. Suramin: an anticancer drug with a unique mechanism of action. J Clin Oncol 1989; 7: 499-508.
38. Mandell G L, Douglas R G Jr, Bennett J E. Principles and Practice of Infectious Diseases, 2nd edition, New York: John Wiley and Sons, 1985: 294-296; 1537-1539; 1571-1572.
39. Rago R, Milchen J, Cheng A-L, Oberley T, Wilding G. Disruption of cellular energy balance by suramin in intact human prostatic carcinoma cells, a likely antiproliferative mechanism. Cancer Res 1991; 51: 6629-6635.
40. Barnard J A, Lyons R M, Moses H L. The cell biology of transforming growth factor β. Biochim Biophys Acta 1990; 1032: 79-87.
41. McKeehan W L, Adams P S. Heparin-binding growth factor/prostatropin attenuates inhibition of rat prostate tumor epithelial cell growth by transforming growth factor type beta. In Vitro 1988; 24: 243-246.
42. Houck K A, Zarnegar R, Muga S J, Michalopolous G K. Acidic fibrobfast growthfactor (HBGF-1) stimulates DNA synthesis in primary rat hepatocyte culture. J Cell Physiol 1990; 143: 129-132.
43. Massague J. The TGF-β family of growth and differentiation factors. Cell 1987; 49: 437-438.
44. Cunliffe W J, Miller A J. Retinoid Therapy. Boston: MT Press Lmt 1984.
45. Marchese C, Rubin J, Ron D, Faggioni A, Torrisi M R, Messina A, Frati L, Aaronson S A. Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes K.GF from EGF family. J Cell Physiol 1990; 144: 326-332.
46. Story M T, Livingston B, Baeten L, Swartz S J, Jacobs S C, Begun F P, Lawson R K. Cultured human prostate-derived fibroblasts produce a factor that stimulates their growth with properties indistinguishable from basic fibroblast growth factor. Prostate 1989; 15: 355-365.
47. Hierowski M T, McDonald M W, Dünn L, Sullivan J W. The partial dependency of human prostatic growth factor on steroid hormones in stimulating thymidine incorporation into DNA. J Urol 1987; 138: 909-912.
48. Mori H, Maki M, Oishi K, Jaye M, Igarashi K, Yoshida O, Hatanaka M. Increased expression of genes for basic fibroblast growth factor and transforming growth factor type β2 in human benign prostatic hyperplasia. Prostate 1990; 16: 71-80.
49. Story M R, Sasse J, Jacobs S C, Lawson R K. Prostatic growth factor: purification and structural relationship to basic fibroblast growth factor. Biochem 1987; 26: 3843-3849.
50. Mydlo J H, Michaeli J, Heston W D W, Fair W R. Expression of basic fibroblast growth factor mRNA in benign prostatic hyperplasia and prostatic carcinoma. Prostate 1988; 13: 241-247.
51. Folkman J, Klagsbrun S D. Angiogenic factors. Science 1987; 235: 442-447.